基本資料
種類: ETF
費用比率%: 0.60
資產淨值: 31.72
成立日期: 11/12/2017
 
分析
市值分佈:
74.04%
大市值
3.95%
中市值
1.36%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 14/11/2026 05:06) 總持有投資項目: 314  
0%
 
100%
     10大 (23.97%)
代號 名稱 佔比% ▼ 持有日期
CADLCandel Therapeutics0.0430/10/2026
CRVSCorvus Pharmaceuticals0.0430/10/2026
COHRCoherent Corp0.0430/10/2026
VSTMVerastem0.0430/09/2026
MCHPMicrochip Technology0.0330/10/2026
ALGNAlign Technology0.0330/10/2026
UHSUniversal Health Services0.0330/10/2026
PRMEPrime Medicine0.0330/10/2026
NTAPNetApp0.0330/10/2026
WDAYWorkday0.0330/09/2026
QUITAchieve Life Sciences Inc.0.0330/09/2026
PEverpure Inc0.0330/10/2026
GERNGeron Corp0.0330/10/2026
KLRAKailera Therapeutics Inc0.0330/10/2026
IMMXImmix Biopharma0.0330/10/2026
DMRADamora Therapeutics, Inc.0.0330/10/2026
SVRASavara0.0330/10/2026
OLMAOlema Oncology Inc0.0330/10/2026
RGNXREGENXBIO0.0330/09/2026
SANASana Biotechnology0.0330/10/2026
  1    2    3    4    5    6    7    8    9    10    11    12   13    14    15    16  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.